|
2015 Conference Publication A randomized trial of olanzapine and palonosetron versus infused ondansetron for the treatment of chemotherapy induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantationNakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2015). A randomized trial of olanzapine and palonosetron versus infused ondansetron for the treatment of chemotherapy induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. 57th ASH Annual Meeting, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v126.23.1910.1910 |
|
2015 Conference Publication A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell TransplantationNakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2015). A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation. 57th Annual Meeting of the American Society of Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. |
|
2015 Journal Article Hospital pharmacists' perceptions of medication counseling: a focus group studyChevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neill (2015). Hospital pharmacists' perceptions of medication counseling: a focus group study. Research in Social and Administrative Pharmacy, 12 (5), 756-771. doi: 10.1016/j.sapharm.2015.10.007 |
|
2015 Journal Article Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapyLindsay, Julian N. and Barras, Michael (2015). Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy. Journal of Oncology Pharmacy Practice, 21 (4), 293-295. doi: 10.1177/1078155214527859 |
|
2015 Journal Article Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patientsMarotti, Sally B., Barras, Michael and Kirkpatrick, Carl (2015). Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Therapeutic Drug Monitoring, 37 (1), 33-39. doi: 10.1097/FTD.0000000000000099 |
|
2015 Book Chapter Peri-procedural anticoagulationBarras, Michael (2015). Peri-procedural anticoagulation. Anticoagulation management: a guide for pharmacists . (pp. 179-199) edited by Anne Rose. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-22602-6_8 |
|
2015 Journal Article Engaging pharmacists in clinical researchBarras, Michael (2015). Engaging pharmacists in clinical research. Australian Journal of Pharmacy, 96 (1139) |
|
2014 Journal Article Improving Care Transitions in Individuals Frequently Admitted to the HospitalMudge, Alison M., Barras, Michael, Adsett, Julie, Mullins, Robert W., Lloyd, Sophie and Kasper, Karen (2014). Improving Care Transitions in Individuals Frequently Admitted to the Hospital. Journal of the American Geriatrics Society, 62 (10), 1994-1996. doi: 10.1111/jgs.13033 |
|
2014 Journal Article The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison, Khatun, Mohsina and Barras, Michael (2014). The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Supportive Care in Cancer, 23 (1), 71-78. doi: 10.1007/s00520-014-2322-0 |
|
2014 Journal Article Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approachesLindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison and Barras, Michael (2014). Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Supportive Care in Cancer, 22 (4), 1113-1119. doi: 10.1007/s00520-013-2098-7 |
|
2014 Journal Article Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspectiveJamsen, Kris M., McLeay, Sarah C., Barras, Michael A. and Green, Bruce (2014). Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective. Clinical Pharmacokinetics, 53 (2), 111-122. doi: 10.1007/s40262-013-0114-1 |
|
2013 Journal Article Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology settingBarras, Michael, Moore, Diana, Pocock, Daniel, Sweedman, Myles, Wilkinson, Cathy, Taylor, Kerry and Morton, James (2013). Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting. Journal of Oncology Pharmacy Practice, OnlineFirst (5), 1-10. doi: 10.1177/1078155213504443 |
|
2013 Journal Article Abnormal laboratory results: anti-Xa assaysBarras, Michael (2013). Abnormal laboratory results: anti-Xa assays. Australian Prescriber, 36 (3), 98-101. doi: 10.18773/austprescr.2013.036 |
|
2013 Conference Publication Implementation and Evaluation of an Interprofessional CurriculumCottrell, Neil, Waller, Susan, Barras, Michael, Burston, Adam, Dickie, Robyn, Groves, Michele, Kendall, Bradley and Rylands, Linda (2013). Implementation and Evaluation of an Interprofessional Curriculum. Collaborating Across Borders III (CAB III) Interprofessional Collaboration: From Concept to Preparation to Practice, Tucson, AZ, United States, 19-21 November 2011. London, United Kingdom: Informa Healthcare. doi: 10.3109/13561820.2013.761518 |
|
2012 Journal Article Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?Iedema, Joel, Barras, Michael, Sundac, Lana and Coombes, Ian (2012). Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?. Australian Prescriber, 35 (2), 64-65. doi: 10.18773/austprescr.2012.029 |
|
2012 Journal Article Gentamicin use - more clinical outcome evidence neededMartin, Jennifer, Norris, Ross and Barras, Michael (2012). Gentamicin use - more clinical outcome evidence needed. Journal of Clinical Toxicology, 2 (6), e110.1-e110.2. doi: 10.4172/2161-0495.1000e110 |
|
2012 Journal Article Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trialMartin, Jennifer, Barras, Michael, Yui, Nicholas Ah, Kirkpatrick, Carl, Kubler, Paul and Norris, Ross (2012). Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. Journal of Clinical Toxicology, 2 (8), 146.1-146.5. doi: 10.4172/2161-0495.1000146 |
|
2011 Journal Article Recurrent readmissions in medical patients: A prospective studyMudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811 |
|
2011 Conference Publication Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosisNorris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba |
|
2011 Journal Article Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosisBarras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x |
